View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.WebsiteVideoWhat do you #DiscoverCareBelieve?
Dana-Farber's Alan D'Andrea, MD, has been selected to lead a Stand Up To Cancer Dream Team devoted to ovarian cancer research. The team will focus on DNA repair therapies for ovarian cancer.
Clinicians at Dana-Farber/Brigham and Women'’s Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.
Bruce Spiegelman, PhD, Dana-Farber Cancer Institute, has received Belgium’s most important international scientific
prize for his contributions to understanding the mechanisms of metabolic
In new study,
researchers at Dana-Farber Cancer Institute show that disruptions
to the activity of cell proteins can reveal which genetic mutations lead to
disease and which are mere bystanders
Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health in Boston and the Irish Cancer Society have formed the Boston-Ireland Prostate Cancer Collaboration. This new entity will conduct and facilitate exchanges of researchers and knowledge between Boston and Ireland.
Dr. Mehra Golshan led a study that shows many patients are
opting for a mastectomy despite the high success rates a lumpectomy can offer.
Dr. F. Stephen Hodi co-led a study that found combining two drugs that unleash the immune system to attack cancer was significantly more effective in stifling tumors in melanoma patients than using just one of the treatments alone.
K. "Vish" Viswanath, PhD was a panelist for a discussion titled "Can E-cigarette Regulation Protect the Public’s Health? Making Sense of the Science."
Dr. Joanne Wolfe commented on the pressing need for improvements in the care of pediatric cancer patients, despite research showing increased survival rates in the group.
Dr. Rosalind Segal led a study that identified a protein critical to both the normal development of the brain and the development of medulloblastoma, a fast-growing brain tumor that usually strikes children younger than 10.
A patient at Dana-Farber who was treated by
Dr. Keith Ligon “open-sourced” his illness by inviting
friends, family, and colleagues in the field of science, to view his health information and have discussions about his treatment.
Dana-Farber nutritionist Stacy Kennedy, MPH, commented on a recent survey that found
many people with cancer were taking fish oil supplements despite research
showing they make chemotherapy less effective.
Zakim Center Drum Circle
11:00 AM - 12:00 PM
Smith Building, Room 330
Explore, express, and experience the empowering effects of drum circles with music therapist Heather Smist as your guide. We'll learn how drumming can reduce stress and increase self-awareness, then practice it ourselves. Drums provided. No experience necessary. Call 617-632-3322 or email Zakim_Center@dfci.harvard.edu to register. Open to patients, family members and staff.
Brain Tumor Support Group
1:30 PM - 3:00 PM
Smith Building, Room 335
Support for brain tumor patients and their caregivers facilitated by Debra LaFrankie, RN, OCN and Nancy Tharler, LICSW.
Registration is required. Please call Nancy Tharler to register at 617-632-3634.
For more information on adult patient/family support groups & programs or to connect with a social worker at Dana-Farber/Brigham & Women’s Cancer Center call: (617) 632-3301 or visit www.dfci.org/supportgroups
Thriving with Yoga - Londonderry
5:30 PM - 6:30 PM
40 Buttrick Road, Londonderry
Presented in cooperation with YogaCaps, Inc. Open to those with a current or past cancer diagnosis. Beginners or people experienced in yoga are welcome. Caregivers may also attend.
Please call 603-670-0302 to register and for other days, times, and/or locations.
Patient referral information, clinical resources and more.
For adults:877-442-3324Quick access: Appointments as soon as the next day for new adult patientsFor children:888-733-4662
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults — #1 in the nation for children's cancer
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: